Onco-Innovations Limited
ONNVF
$2.65
$1.2285.32%
OTC PK
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 0.00% | -- | |||
| SG&A Expenses | -0.01% | 731.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.02% | 642.78% | |||
| Operating Income | 0.01% | -625.40% | |||
| Income Before Tax | 0.02% | -2,021.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.02% | -2,021.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.02% | -2,021.87% | |||
| EBIT | 0.01% | -625.40% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.00% | -2,271.43% | |||
| Normalized Basic EPS | 0.00% | -1,186.36% | |||
| EPS Diluted | 0.00% | -2,271.43% | |||
| Normalized Diluted EPS | 0.00% | -1,186.36% | |||
| Average Basic Shares Outstanding | 0.00% | -11.67% | |||
| Average Diluted Shares Outstanding | 0.00% | -11.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||